Genesis Therapeutics Funding & Investors
Their academia-leading research was the initial component of our expanding portfolio of AI technologies. They are combining novel deep neural networks, biophysical simulation, and massively scalable computing infrastructure to achieve industry-leading performance in a molecular generation and property prediction. The company was founded in 2019 and based in South San Francisco, California.
genesistherapeutics.aiTotal Amount Raised: $256,100,000
Genesis Therapeutics Funding Rounds
Series B
$200,000,000
Series B Investors
Andreessen HorowitzBlackRockT. Rowe PriceRadical VenturesFidelity InvestmentsRock Springs CapitalMenlo VenturesGreen D VenturesNVenturesSeries A
$52,000,000
Series A Investors
Rock Springs CapitalHarpoonMark LeslieAndreessen HorowitzFelicis VenturesOpen Field CapitalUlu VenturesJeffrey RothschildPropagator VenturesRadical VenturesMenlo VenturesJazz Venture PartnersT. Rowe PriceSeed
$4,100,000
Seed Investors
Andreessen HorowitzFelicis Ventures
Funding info provided by Diffbot.